8-(4-benzenesulfonylamino)quinoline has been researched along with spc-839 in 1 studies
Studies (8-(4-benzenesulfonylamino)quinoline) | Trials (8-(4-benzenesulfonylamino)quinoline) | Recent Studies (post-2010) (8-(4-benzenesulfonylamino)quinoline) | Studies (spc-839) | Trials (spc-839) | Recent Studies (post-2010) (spc-839) |
---|---|---|---|---|---|
15 | 0 | 5 | 37 | 0 | 18 |
Protein | Taxonomy | 8-(4-benzenesulfonylamino)quinoline (IC50) | spc-839 (IC50) |
---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 0.0538 | |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | 1.3 | |
Transcription factor AP-1 | Homo sapiens (human) | 0.008 | |
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.008 | |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.344 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2527 | |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.618 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.008 | |
Transcription factor p65 | Homo sapiens (human) | 0.008 | |
Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.344 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auld, DS; Aulner, N; Austin, CP; Branden, L; Cayanis, E; Chung, C; Davis, RE; Deng, S; Gong, G; Huang, W; Inglese, J; Landry, DW; Liu, Y; Pampou, S; Rinderspacher, A; Schürer, S; Smith, DH; Southall, N; Staudt, LM; Thomas, CJ; Többen, U; Vidović, D; Wyler, M; Xie, Y; Zhang, YQ | 1 |
1 other study(ies) available for 8-(4-benzenesulfonylamino)quinoline and spc-839
Article | Year |
---|---|
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.
Topics: Benzenesulfonamides; Combinatorial Chemistry Techniques; Down-Regulation; NF-kappa B; Quinolines; Structure-Activity Relationship; Sulfonamides | 2008 |